Found: 33
Select item for more details and to access through your institution.
Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Intracellular and plasma pharmacokinetics of 400 mg of etravirine once daily versus 200 mg of etravirine twice daily in HIV-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 3, p. 681, doi. 10.1093/jac/dkr534
- By:
- Publication type:
- Article
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 6, p. 1365, doi. 10.1093/jac/dkn420
- By:
- Publication type:
- Article
Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 4, p. 793, doi. 10.1093/jac/dkn262
- By:
- Publication type:
- Article
Darunavir/cobicistat showing similar effectiveness as darunavir/ ritonavir monotherapy despite lower trough concentrations.
- Published in:
- Journal of the International AIDS Society, 2018, v. 21, n. 2, p. 1, doi. 10.1002/jia2.25072
- By:
- Publication type:
- Article
Liver Toxicity of Antiretroviral Combinations Including Fosamprenavir Plus Ritonavir 1400/100 mg Once Daily in HIV/Hepatitis C Virus-Coinfected Patients.
- Published in:
- AIDS Patient Care & STDs, 2011, v. 25, n. 7, p. 395, doi. 10.1089/apc.2011.0109
- By:
- Publication type:
- Article
Enterococcus faecalis Endocarditis and Outpatient Treatment: A Systematic Review of Current Alternatives.
- Published in:
- Antibiotics (2079-6382), 2020, v. 9, n. 10, p. 657, doi. 10.3390/antibiotics9100657
- By:
- Publication type:
- Article
Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial.
- Published in:
- Stem Cells Translational Medicine, 2021, v. 10, n. 4, p. 534, doi. 10.1002/sctm.20-0213
- By:
- Publication type:
- Article
Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0143492
- By:
- Publication type:
- Article
Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0125080
- By:
- Publication type:
- Article
Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV Coinfected Patients.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0101760
- By:
- Publication type:
- Article
HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients.
- Published in:
- PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0099468
- By:
- Publication type:
- Article
Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0097262
- By:
- Publication type:
- Article
Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-α 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0028115
- By:
- Publication type:
- Article
Increased Regulatory T Cell Counts in HIV-Infected Nonresponders to Hepatitis B Virus Vaccine.
- Published in:
- Journal of Infectious Diseases, 2010, v. 202, n. 3, p. 362, doi. 10.1086/653707
- By:
- Publication type:
- Article
Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 1, p. 1, doi. 10.1002/ctm2.704
- By:
- Publication type:
- Article
Discontinuation of Antiretroviral Therapy in Patients with Chronic HIV Infection: Clinical, Virologic, and Immunologic Consequences.
- Published in:
- AIDS Patient Care & STDs, 2005, v. 19, n. 9, p. 550, doi. 10.1089/apc.2005.19.550
- By:
- Publication type:
- Article
High-risk Human Papilloma Virus Testing Improves Diagnostic Performance to Predict Moderate- to High-grade Anal Intraepithelial Neoplasia in Human Immunodeficiency Virus–infected Men Who Have Sex With Men in Low-to-Absent Cytological Abnormalities.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 12, p. 2185, doi. 10.1093/cid/ciz144
- By:
- Publication type:
- Article
Viral Kinetics in Semen With Different Antiretroviral Families in Treatment-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 4, p. 551, doi. 10.1093/cid/cix358
- By:
- Publication type:
- Article
A 24-Week Treatment Strategy With Pegylated Interferon/Ribavirin in HIV/Hepatitis C Virus Genotype 3–Coinfected Patients Who Achieved a Rapid Virologic Response Results in a High Sustained Virologic Response Rate.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 1, p. 130
- By:
- Publication type:
- Article
Risk of Liver Decompensation Among HIV/Hepatitis C Virus–Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 10, p. 1401, doi. 10.1093/cid/cit537
- By:
- Publication type:
- Article
Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0148924
- By:
- Publication type:
- Article
Plasma concentrations of IL-6, MIP-1β, IP-10, and PTX-3 as predictors of the immunological response to antiretroviral treatment in people with HIV.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1447926
- By:
- Publication type:
- Article
Stepped-dose versus full-dose efavirenz for HIV infection and neuropsychiatric adverse events: a randomized trial.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Stepped-Dose Versus Full-Dose Efavirenz for HIV Infection and Neuropsychiatric Adverse Events.
- Published in:
- Annals of Internal Medicine, 2009, v. 151, n. 3, p. 149
- By:
- Publication type:
- Article
Comparison of Two Methods for the Assessment of Delayed-Type Hypersensitivity Skin Responses in Patients with Human Immunodeficiency Virus Infection.
- Published in:
- Clinical Infectious Diseases, 1998, v. 26, n. 6, p. 1330
- By:
- Publication type:
- Article
Digital Necrosis Due to Leishmania Species Infection in a Patient with AIDS.
- Published in:
- Clinical Infectious Diseases, 1998, v. 26, n. 1, p. 198, doi. 10.1086/517065
- By:
- Publication type:
- Article
Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus–Coinfected Patients With Compensated Cirrhosis.
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 11, p. 1646
- By:
- Publication type:
- Article
Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus–Coinfected Patients With Compensated Liver Cirrhosis.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. 12, p. 1719, doi. 10.1093/cid/cis779
- By:
- Publication type:
- Article
Natural History of Compensated Hepatitis C Virus–Related Cirrhosis in HIV-Infected Patients.
- Published in:
- Clinical Infectious Diseases, 2009, v. 49, n. 8, p. 1274, doi. 10.1086/605676
- By:
- Publication type:
- Article
Efficacy, safety and pharmacokinetic of once-dailyboosted saquinavir (1500/100 mg) together with2 nucleos(t)ide reverse transcriptase inhibitors inreal life: a multicentre prospective study.
- Published in:
- AIDS Research & Therapy, 2010, v. 7, p. 5
- By:
- Publication type:
- Article